Invesco’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Buy |
586,883
+541,189
| +1,184% | +$3.47M | ﹤0.01% | 2325 |
|
|
2025
Q1 | $162K | Buy |
+45,694
| New | +$162K | ﹤0.01% | 3543 |
|
|
2024
Q2 | – | Sell |
-24,349
| Closed | -$69.2K | – | 3861 |
|
|
2024
Q1 | $69.2K | Buy |
24,349
+454
| +2% | +$1.29K | ﹤0.01% | 3763 |
|
|
2023
Q4 | $352K | Sell |
23,895
-5,940
| -20% | -$87.4K | ﹤0.01% | 3371 |
|
|
2023
Q3 | $546K | Buy |
29,835
+3,095
| +12% | +$56.7K | ﹤0.01% | 3143 |
|
|
2023
Q2 | $577K | Buy |
26,740
+3,803
| +17% | +$82K | ﹤0.01% | 3150 |
|
|
2023
Q1 | $673K | Sell |
22,937
-192,533
| -89% | -$5.65M | ﹤0.01% | 3100 |
|
|
2022
Q4 | $7.96M | Sell |
215,470
-46,066
| -18% | -$1.7M | ﹤0.01% | 1995 |
|
|
2022
Q3 | $7.36M | Buy |
+261,536
| New | +$7.36M | ﹤0.01% | 1986 |
|